Impact of malignant arterial hypertension on the heart

Philippe Gosse1, Paul Coulon, Georgios Papaioannou

  • 1Hypertension Unit, University Hospital of Bordeaux, Saint André Hospital, 1 rue jean Burguet, Bordeaux, France. philippe.gosse@chu-bordeaux.fr

Journal of Hypertension
|December 24, 2010
PubMed

Insights

Malignant hypertension significantly impairs left-ventricular systolic function. However, prompt antihypertensive treatment leads to rapid recovery of heart function and reduction in hypertrophy.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Cardiovascular Imaging

Background:

  • Malignant hypertension serves as a model for studying the effects of extreme blood pressure and renin-angiotensin system activity on organs.
  • Limited research exists on the specific cardiac consequences of malignant hypertension.

Purpose of the Study:

  • To evaluate the impact of malignant hypertension on left-ventricular function.
  • To assess the evolution of cardiac function during antihypertensive treatment.

Main Methods:

  • A prospective echocardiographic study was conducted from January 2004 to June 2009.
  • Assessed left-ventricular function and hypertrophy in patients with malignant hypertension.
  • Utilized global longitudinal strain as a sensitive measure of systolic function.

Main Results:

  • 25 patients with malignant hypertension exhibited baseline left-ventricular hypertrophy and impaired systolic function.
  • Global longitudinal strain was significantly reduced in over half of the patients.
  • Short-term follow-up revealed rapid improvement in systolic function and hypertrophy regression.
  • Long-term follow-up showed normalization of global longitudinal strain and continued hypertrophy regression.

Conclusions:

  • Malignant hypertension profoundly affects left-ventricular systolic function.
  • Antihypertensive treatment enables swift recovery of normal systolic function in the left ventricle.
Abstract

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...